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CD4þ T Cells in Lymph Nodes of UVB-Irradiated
Mice Suppress Immune Responses to New Antigens
Both In vitro and In vivo
Shelley Gorman1, Jamie W.-Y. Tan1, Stephanie T. Yerkovich1, John J. Finlay-Jones1 and Prue H. Hart1
The mechanisms by which erythemal UVB irradiation modulates systemic immune responses to antigens
applied to non-irradiated sites are poorly understood. In this study, regulatory CD4þ T cells were identified in
the skin-draining lymph nodes (SDLNs) of UVB-irradiated, but otherwise naive mice. A transgenic mouse strain
(DO11.10) was utilized in which the majority of CD4þ T cells expressed the ovalbumin (OVA323–339) T-cell
receptor. Thus, T-cell responses could be examined following erythemal UVB irradiation without further antigen
sensitization. CD4þ T cells from the SDLNs of UVB-irradiated mice had significantly reduced capacity to
respond to presentation of the OVA323–339 peptide in vitro. Transfer of CD4þ T cells from the SDLNs of UVB-
irradiated antigen-naive mice significantly reduced both OVA sensitization and contact hypersensitivity
responses to an experimental hapten in the recipient mice. Depletion of CD4þCD25þ cells abrogated this
UVB-suppressive effect in the in vitro proliferation assay. There was also a significant increase in the proportion
of CD4þCD25þ Foxp3þ cells in the SDLNs of UVB-irradiated mice. The potential of these regulatory cells
poised to regulate responses to incoming antigens at distant non-irradiated sites broadens the biological impact
of UVB irradiation of skin on immunity.
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INTRODUCTION
UV light is one of the most important environmental
carcinogens for humans. UV radiation, in particular UVB
(280–320 nm), also suppresses immune responses as shown in
experimental models where irradiated mice will not reject
immunogenic skin tumors (Fisher and Kripke, 1977), and
have suppressed contact hypersensitivity (CHS) responses
(Kripke, 1984) and increased susceptibility to infection
(Norval et al., 1999). The mechanisms of UVB-induced local
immunosuppression have been extensively investigated by
applying a sensitizing agent or hapten to irradiated skin.
There is altered Langerhans cell antigen presentation in the
lymph nodes, and less efficient handling of antigens by
immature dermal and hair-follicle-derived dendritic cells
when these antigens are applied before (Schwarz et al., 2005)
or following (Hammerberg et al., 1994) antigen-presenting
cell (APC) migration, respectively. Mechanisms of systemic
immunosuppression are less well defined, but require the
sensitizing agent to be applied to a site distant to that
irradiated at least 3 days earlier with erythemal doses of UVB
(Noonan and Hoffman, 1994). UVB-induced mediators from
keratinocytes (Rivas and Ullrich, 1992, Shreedhar et al.,
1998) and other skin cells including mast cells (Hart et al.,
1997, 1998) may initiate systemic immunosuppression.
Recent studies of local immunosuppression have shown
that adoptive transfer of cells from the skin-draining lymph
nodes (SDLNs) and spleens of irradiated, hapten-sensitized
mice suppresses CHS responses to that same hapten in
recipient mice (Aubin, 2003). The identified regulatory cells
express CD4, CD25, and CTLA-4 (Schwarz et al., 2000,
2004). DNA damage to Langerhans cells in the irradiated skin
may be required for the induction of these antigen-specific
T regulatory cells (Schwarz et al., 2005), which in turn
require IL-10 to cause UV-induced tolerance (Ghoreishi and
Dutz, 2006). T regulatory cells are also functionally important
in models of photo-carcinogenesis (Fisher and Kripke, 1982,
Ullrich and Kripke, 1984) and systemic immunosuppression
(Beissert et al., 1999, Moodycliffe et al., 2000, Loser et al.,
2005). In these models, roles for CTLA-4þ (Beissert et al.,
1999, Loser et al., 2005) and natural killer T cells
(Moodycliffe et al., 2000) have been identified, which may
act by secreting IL-4.
A two-signal paradigm is thought to be required for UV
induction of regulatory cells, where antigen-specific cells are
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generated only after UV-associated, ‘altered’ (suboptimal)
presentation of antigen. This dogma was initially based on
early papers (Kripke et al., 1983, Ullrich, 1985), where
adoptive transfer of T cells from UV-irradiated but not
hapten-sensitized mice did not suppress subsequent hapten-
specific immune responses. Some recent findings suggest that
there may be additional UV-induced T regulatory cells.
A 40–50% increase in the proportion of CD4þCD25þ T
regulatory cells was detected in the SDLNs and spleens of
mice chronically irradiated with UVB (Loser et al., 2005,
Ghoreishi and Dutz, 2006). In our study, we utilized a
transgenic mouse strain, in which X85% of CD4þ T cells
express the ovalbumin (OVA323–339) T-cell receptor. An
advantage of using this mouse is that OVA-specific responses
can be investigated without a direct requirement for antigen
sensitization (and avoiding potential effects of UV on OVA-
presenting APC in the sensitization phase). We demonstrate
that CD4þ T cells from the SDLNs of UVB-irradiated mice
but otherwise naive mice had a significantly reduced
capacity to respond to the presentation of OVA both in vitro,
and after transfer to naive recipient mice, suppressed OVA-
specific sensitization and non-OVA-specific CHS responses.
Depletion of CD25þ cells removed the difference in proli-
feration by CD4þ T cells from control and UVB-irradiated
mice and suggested that reduced proliferation was due to
UVB-induced CD25þ regulatory T cells. With concomitant
increases in CD25 and Foxp3 expression by CD4þ T cells in
the SDLNs, these results highlight an immunosuppressive role
for activated CD4þCD25þ T regulatory cells in the SDLNs
of UV-irradiated but antigen-naive mice.
RESULTS
CD4þ T cells from the SDLNs of UVB-irradiated OVA-TCR
transgenic mice have reduced proliferative responses in vitro
The shaved backs of OVA323–339-specific T-cell receptor
(TCR)-ab transgenic (DO11.10) mice were irradiated with
8 kJ/m2 UVB, a dose that significantly suppresses systemic
CHS responses and is equivalent to 2–3 minimal edemal
doses (Noonan and Hoffman, 1994, Hart et al., 1998). Four
days after UVB irradiation, the SDLNs were removed from
irradiated and mock-treated (control) mice and cultured with
1 mg/ml of OVA323–339 peptide (ISQAVHAAHAEINEAGR) for
96 hours. 3H-thymidine incorporation during the last 48 hours
of culture was significantly reduced by a mean of 28%
(Po0.0001, n¼3) in cells from UVB-irradiated mice (data
not shown). To determine if the reduced proliferation was
within the T-cell population, 4 days after irradiation, CD4þ
T cells were enriched to greater than 95% purity from the
SDLNs of UVB-irradiated and mock-treated OVA-TCR
transgenic mice (H-2d). These cells were cultured at different
ratios with APC enriched from the lymph nodes of naive
BALB/c (H-2d) mice together with OVA323–339 peptide (1 mg/
ml) for 48–120 hours. Proliferation of CD4þ T cells
commenced after 48 hours culture and was maximal by
96 hours (Figure 1a), as determined by the dilution of the
intracellular label 5,6-carboxyfluorescein diacetate, succini-
midyl ester (CFSE) in proliferating cells. At 96 hours, the
number of divided CD4þ T cells from control SDLNs
exceeded that from UVB SDLNs (Figure 1a). Furthermore,
there were greater numbers of undivided CD4þ T cells from
the SDLNs of UVB-irradiated mice (Figure 1c).
Using the proliferation algorithm of the FlowJo analysis
program, the numbers of CD4þ CFSE-lo (proliferated) cells
in control and UVB cultures were compared. The prolifera-
tion of CD4þ T cells from the SDLNs of UVB-irradiated mice
was reduced by 3977% (mean7SEM, n¼8) after 96 hours at
a ratio of 100:1 of CD4þ T cells:APCs. There was no
difference in the expression of OVA-TCR on CD4þCD25þ
(B50%) or CD4þCD25 (X85%, data not shown, n¼ 5)
T cells from the SDLNs of UV-irradiated or control mice.
IL-2 levels in supernatants were significantly reduced at all
times tested in cultures with CD4þ T cells from UVB
SDLNs (Figure 1b) and in repeated experiments (P¼0.005,
n¼8; Figure 1d) after 96 hours culture. There was a signifi-
cant linear correlation between the reduced proliferation of
CD4þ T cells from the SDLNs of UVB-irradiated mice
and reduced IL-2 concentrations at 96 hours (n¼8,
r¼ 0.765, P¼ 0.03). However, there was no difference in
100
80
60
40
20
0
48 hours
CFSE
500
400
300
200
100
800 500 100
80
60
40
20
0
400
300
200
100
0
600
Control UVB Control UVB Control UVB
400
200
0
0
72 hours 96 hours 120 hours
Control
UVB
96 hours
1,500
1,000
500
0
%
 o
f M
ax
100
80
60
40
20
0
%
 o
f M
ax
100
80
60
40
20
0
%
 o
f M
ax
100
80
60
40
20
0
%
 o
f M
ax
48 72 96 120
Time (hours)
IL
-2
 (p
g /m
l)
IL
-2
 (p
g /m
l)
IL
-1
0 
(pg
 /m
l)
IF
N
- 
 
(pg
 /m
l)
Treatment
Control
CFSE
Control
N
o.
 
o
f c
el
ls
UVB
UVB
*
*
* *
*
a
b c
d
Figure 1. Reduced proliferation of CD4þ T cells from the SDLNs of
UVB-irradiated mice. (a) CD4þ T cells were purified from the SDLNs of
OVA-TCR transgenic mice irradiated with 8 kJ/m2 UVB (shaded) and control
(unshaded) mice, labeled with CFSE and cultured with APC (at a ratio of
100:1) and OVA323–339 peptide for up to 120 hours. Proliferation is shown by
dilution of the CFSE label. (b) IL-2 levels in supernatants for three replicates
per treatment (*Po0.05). In (c), results from the 96 hours time point from
(a) are re-graphed with the number of cells on the y axis and the UVB-treated
group now shown by a broken line. (d) Reduced IL-2, but not IFN-g and
IL-10 in supernatants of CD4þ T cells from the SDLNs of UVB-irradiated
mice. Supernatants were harvested after 96 hours culture (n¼8 experiments,
mean7SEM, with three replicates for each treatment per experiment).
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the concentrations of IFN-g or IL-10 in the supernatants of
cultures containing CD4þ T cells from the SDLNs of
irradiated versus control mice (Figure 1d).
Reduced CD4 T-cell responses are maximal 4 days
post-irradiation and are dependent upon UVB dose
To determine when the effect of UVB upon CD4þ T-cell
proliferation was the greatest, SDLN cells were harvested
from OVA-TCR transgenic mice irradiated 2, 4, 7, or 14 days
earlier with 8 kJ/m2 UVB. At these times, CD4þ T cells were
purified from the SDLNs and cultured with APC and OVA
peptide. After 96 hours in vitro, CD4þ T-cell proliferation
was diminished maximally at 4 days post-irradiation (Figure
2a). To determine the effect of the dose of UVB upon the
capacity of CD4þ T cells from the OVA-TCR transgenic
mice to proliferate ex vivo, mice were irradiated with 2, 4, or
8 kJ/m2 of UVB. Four days after irradiation, CD4þ T cells
were purified from the SDLNs and cultured with APC and
OVA peptide. After 96 hours, proliferation of CD4þ T cells
was dependent upon the UVB dose, which was significantly
reduced after irradiation with 4 or 8 kJ/m2 UVB (Figure 2b).
The effect of multiple irradiations was also investigated. The
OVA-TCR transgenic mice were irradiated up to four times
with 4 kJ/m2 UVB administered weekly. A 4 kJ/m2 dose was
selected as a significant reduction of CD4þ T-cell prolifera-
tion in vitro was detected previously (Figure 2b). Four days
after the fourth UVB treatment, CD4þ T cells were purified
from the SDLNs and cultured with APC and OVA peptide.
The irradiation of DO11.10 mice with four weekly doses of
4 kJ/m2 suppressed CD4þ T-cell proliferation to no greater
extent than that observed in cultures from the SDLNs of mice
irradiated with one dose of 8 kJ/m2 (Figure 2c). Thus, multiple
UVB irradiations did not further reduce the ability of CD4þ
T cells from the SDLNs to proliferate in vitro.
Sensitization with OVA is reduced in BALB/c recipients of
CD4þ T cells from the SDLNs of UVB-irradiated OVA-TCR
transgenic mice
To determine if the CD4þ T cells from the SDLNs of UVB-
irradiated mice could alter antigen sensitization in vivo,
CD4þ T cells were purified from the SDLNs of UVB-
irradiated (4 days after 8 kJ/m2 UVB), or control OVA-TCR
transgenic mice and 5 106 cells adoptively transferred by
tail-vein injection into naive BALB/c mice. After 18 hours,
recipient mice were sensitized by intraperitoneal injection of
20 mg OVA protein with 4 mg of Alum adjuvant. For three
experiments, at 24 and 72 hours post-sensitization, the
parathymic lymph nodes (PLNs) and spleens (both part of
the lymphatic system that drains the peritoneal cavity) were
collected from recipient mice. In recipients of cells from
control mice, the cellularity of the PLNs increased by a mean
of 102% from 24 to 72 hours post-sensitization. In UVB
recipients, the cellularity of the PLNs increased on average by
only 36% (Table 1). At 72 hours, there were 34% more PLN
cells in recipients of control CD4þ T cells, when compared
to numbers observed in recipients of cells from UVB-
irradiated mice (Table 1). In these same three experiments,
spleen cells were removed at 24 hours post-sensitization and
stimulated with or without 100 mg/ml OVA for 4 days in vitro.
There was a significant reduction in 3H-thymidine incorpora-
tion by spleen cells from the recipients of CD4þ T cells from
UVB-irradiated mice when cells were stimulated in vitro with
or without OVA protein (Table 1). Thus, sensitization to OVA
was reduced in BALB/c recipients of CD4þ T cells from the
SDLNs of UVB-irradiated OVA-TCR transgenic mice.
CD4þ T cells from the SDLNs of UVB-irradiated OVA-TCR
transgenic mice suppress CHS responses in vivo in both
transgenic and non-transgenic mice
The CHS assay was used to determine whether CD4þ T cells
from UVB-irradiated OVA-TCR transgenic mice could alter
non-OVA-specific immune responses in vivo. Four days
following treatment with 8 kJ/m2 UVB, CD4þ T cells were
purified from the SDLNs of irradiated and control OVA-TCR
transgenic mice and 1.5 107 cells adoptively transferred via
tail-vein injection into naive BALB/c mice. Mice were
sensitized to the hapten 2,4-dinitrofluorobenzene (DNFB)
on the shaved belly 24 hours after CD4þ T-cell transfer.
After 5 days, the ear-swelling response was measured by
painting the ears with DNFB. BALB/c mice that were only
irradiated with 8 kJ/m2 or mock-treated were also included.
Irradiation of BALB/c mice with UVB significantly sup-
pressed the ear-swelling response by 44% as compared
with responses observed in non-irradiated control mice
(Po0.0005; Figure 3). Adoptive transfer of 1.5107
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Figure 2. Reduced proliferation of CD4þ T cells from the SDLNs of
irradiated mice is dependent upon the timing and dose of UVB. CD4þ
T cells were purified from the SDLNs of OVA-TCR transgenic mice (a) 2, 4,
7, or 14 days after irradiation with 8 kJ/m2 UVB, (b) 4 days after irradiation
with 2, 4, or 8 kJ/m2 UVB, or (c) 4 days after the last of 4 weekly doses of
4 kJ/m2. For (a–c), CD4þ T cells were also purified from the SDLNs of
control mice. CD4þ T cells were labeled with CFSE and cultured with APC
(at a ratio of 100:1) and OVA323–339 peptide for 96 hours. Data are shown
as mean7SEM, n¼ 3.
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CD4þ T cells from the SDLNs of UVB-irradiated OVA-TCR
transgenic mice significantly reduced ear swelling by 28% in
comparison with responses in mice that had received CD4þ
cells from the SDLNs of non-irradiated mice (Po0.05;
Figure 3). Similarly, CD4þ T cells (1.5107) from the
SDLNs of UVB-irradiated BALB/c non-transgenic mice
significantly reduced ear swelling by 2673% in BALB/c
recipients in comparison with responses observed in reci-
pients of cells from non-irradiated BALB/c mice (mean7SEM,
n¼5, data not shown). In a preliminary study, the adoptive
transfer of 5106 CD4þ T cells from the SDLNs of
UVB-irradiated OVA TCR transgenic mice nonsignificantly
suppressed ear-swelling responses (data not shown).
Increased percentage of CD4þCD25þ cells in the SDLNs of
UVB-irradiated OVA-TCR transgenic mice
The above experiments demonstrate that CD4þ T cells from
the SDLNs of UVB-irradiated OVA-TCR transgenic mice have
a reduced ability to respond to newly introduced antigens
both in vitro and in vivo. An activated regulatory cell among
the CD4þ T cells from the SDLNs of UVB-irradiated mice
was sought. The CD4þCD25þ T-cell subset constitutes an
important regulatory population in naive mice, where
between 5 and 10% of circulating CD4þ T cells also
express CD25 (Sakaguchi et al., 1995). In the SDLNs of
OVA-TCR transgenic mice, there was a significant increase
in cellularity as well as the percentage of CD3þCD4þ
CD25þ T cells (Table 2). Within the CD3þCD4þ T-cell
population, the percentage of CD25þ T cells significantly
increased by 30% 4 days after irradiation with 8 kJ/m2 UVB
(Table 2). The percentage of CD3þCD4þCD25þ cells was
maximal at 4 days post-UVB (data not shown), and correlated
with reduced CD4þ T-cell proliferation observed in vitro
when mice were irradiated 2, 4, 7, or 14 days earlier
(r¼0.88, Po0.05; Figure 2a). The percentage of CD3þ
CD4þCD25þ cells in the SDLNs also correlated with the
dose of UVB (Figure 2b) used to irradiate mice (r¼0.985,
P¼0.02). Multiple irradiations with UVB (see Figure 2c) did
not increase to any greater extent the percentage of
CD3þCD4þCD25þ cells in the SDLNs of OVA-TCR
transgenic mice (data not shown).
Increased proportion of Foxp3þ cells among CD4þ T cells
from the SDLNs of UVB-irradiated OVA-TCR transgenic mice
As well as being a marker for CD4þ T regulatory cells, CD25
is also upregulated on activated T cells in vivo (Bour-Jordan
and Blueston, 2002). Thus, to ensure that the increased
percentage of CD4þCD25þ cells in the SDLNs of
Table 1. Sensitization to OVA is reduced in BALB/c
recipients of CD4+ T cells from the SDLN of
UVB-irradiated OVA-TCR transgenic mice
PLN cells2
(number per mouse) (h)
Spleen cells3
(3H-thymidine incorporation)
(counts/min)
Treatment1 24 72 OVA +OVA
Control
Exp. 1 6.3 106 6.9 106 0.5103 6.3 103
Exp. 2 4.5 106 9.6 106 1.9103 5.2 103
Exp. 3 3.2 106 1.2 107 1.3103 9.8 103
Mean 4.7 106 9.5 106 1.2103 7.1 103
UVB
Exp. 1 5.3 106 3.8 106 0.2103* 1.9 103*
Exp. 2 4.5 106 6.4 106 0.4103* 0.5 103*
Exp. 3 5.7 106 1.1 107 0.8103 6.6 103*
Mean 5.2 106 7.1 106* 0.5103 3.0 103*
OVA, ovalbumin; PLN, parathymic lymph nodes; SDLN, skin-draining
lymph nodes; TCR, T-cell receptor.
1For each experiment, PLNs or spleen cells from three mice were pooled
within treatments. CD4+ T cells were purified from the SDLN of controls
or mice irradiated 4 days earlier with 8 kJ/m2 UVB, and then adoptively
transferred into naive BALB/c mice (n=3). After 18 h, recipient mice were
intraperitoneally sensitized with 20 mg OVA and 4 mg Alum.
2The number of all PLN cells was determined at 24 and 72 h following
OVA sensitization.
3Spleen cells at 24 h post-OVA sensitization were removed from recipient
mice and cultured with 100mg/ml of OVA protein for 96 h in vitro with
3H-thymidine added for the final 48 h.
*A significant (Po0.05) reduction after 72 h in the number of PLN cells
(n=3 experiments) or 3H-thymidine incorporation by spleen cells
(individual experiments or grouped) when recipients of CD4+ T cells
from control mice were compared with those from UVB-irradiated mice.
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Figure 3. Adoptively transferred CD4þ T cells purified from the SDLNs of
UVB-irradiated mice suppress CHS responses in vivo. CD4þ cells were
isolated from donor mice 4 days following irradiation with 8 kJ/m2 UVB
(shaded) or sham treatment (unshaded). Purified CD4þ T cells (1.5 107)
from the SDLNs of OVA-TCR transgenic mice were adoptively transferred into
naive BALB/c mice. Non-irradiated (‘‘Control’’) and UVB-irradiated (‘‘UVB’’)
mice provided controls for these adoptive transfers. For the sensitization of all
mice, the shaved abdomens were painted with DNFB 24 hours after adoptive
transfer of cells. After 5 days, the pinnae of each ear were painted with
DNFB. Ear-swelling responses were measured 24 hours after ear challenge.
Significantly different (Po0.05) ear-swelling responses are denoted by an
asterisk, where results from sham-irradiated mice were compared with
those from irradiated mice, and results from mice that received control
CD4þ cells (‘‘control CD4þ ’’) compared with those that received
CD4þ cells from UVB-irradiated mice (‘‘UVB CD4þ ’’). Data are shown
as mean7SEM, n¼ 10.
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UVB-irradiated OVA-TCR transgenic mice was due to the
activation/accumulation of CD4þCD25þ T regulatory cells,
a better regulatory cell marker was sought. The forkhead
winged helix family transcription factor Foxp3 may be the
most accepted marker of CD4þ regulatory T cells (Coffer and
Burgering, 2004). There was a significant increase in the
proportion of CD3þCD4þ T cells expressing intracellular
Foxp3 protein in the SDLNs of UVB-irradiated mice (Table 2),
where the majority of CD3þCD4þCD25þ cells also
expressed Foxp3. Using real-time reverse transcription-PCR,
Foxp3 mRNA levels relative to the housekeeping gene
(eucaryotic translation elongation factor 1a) were also
significantly increased in purified CD3þCD4þ T from the
SDLN cells of UVB-irradiated mice as compared with control
mice (P¼ 0.01, n¼ 3, data not shown). The percentage of
CD3þCD4þCD25þ Foxp3þ T cells in the SDLNs was
significantly increased by 24% in the SDLNs of UVB-
irradiated mice (Table 2). There was no difference in mRNA
expression by CD4þCD25 cells or CD4þCD25þ purified
from the SDLNs of control or UVB-irradiated mice (data not
shown). The amount of Foxp3 protein per cell also did not
differ among control and UVB-irradiated cells from any of the
analyzed populations as determined by comparing the mean
fluorescent intensities of the cells incubated with the FITC-
conjugated antibody to Foxp3 (data not shown). These data
suggest that the proportion of CD3þCD4þCD25þ Foxp3þ
T regulatory cells increased in the SDLNs of mice, 4 days after
UVB-irradiation. The expression of a variety of other
T-cell activation, memory, and regulatory markers was also
determined. There was no difference in the percentage of
CD4þCD25þ or CD4þCD25 T cells positive for CD62L
(L-selectin), CD69 (very early activation), CD103 (mucosal
regulatory), CD54 (ICAM-1, adhesion), and CD44 (activation/
memory) or the amount of each marker upon each cell
type from the SDLNs of UVB-irradiated or control mice (data
not shown).
Reduced in vitro proliferation of CD4þ T cells from
UVB-irradiated mice is due to CD4þCD25þ cells
To determine whether CD4þCD25þ regulatory T cells
were responsible for the reduced proliferation observed
in vitro, CD4þ T-cell populations were depleted of
CD25þ cells. Removal of the CD25þ cells enhanced the
proliferation of CD4þ T cells from the SDLNs of UVB-
irradiated mice (Figure 4a, dotted line). CD4þCD25 T cells
from the SDLNs of control and UVB-irradiated mice
proliferated to an equivalent extent, with proliferation greater
than that detected for CD4þ T cells from control mice
(Figure 4a). After depletion of CD25þ cells, IL-2 levels were
significantly enhanced in culture supernatants (Figure 4b).
The addition of 2 ng/ml rIL-2 every 24 hours enhanced
proliferation (n¼ 2; Figure 4c) and IL-2 levels (data not
shown) in CD4þ T-cell cultures and similarly removed the
differential in-proliferation between cells from control and
UVB-irradiated mice. Thus, the increased percentage of
CD4þCD25þ T cells in the SDLNs of UVB-irradiated mice
is responsible for the suppressive effects upon T-cell
proliferation in vitro.
One way that CD4þCD25þ T regulatory cells from the
SDLNs of UVB-irradiated mice could suppress CD4þ T
effector cell proliferation in vitro is by inducing tolerogenic
properties in co-cultured dendritic cells via the tryptophan
catabolic pathway (Fallarino et al., 2003). CTLA-4 expressed
by the T regulatory cells out-competes CD28 for B7 ligands
expressed by dendritic cells, resulting in the secretion of
indoleamine 2,3-dioxygenase (Mellor and Munn, 2004). This
enzyme then degrades tryptophan, where diminished con-
centrations of this amino acid reduce the ability of T cells to
proliferate. Greater than 80% of CD4þCD25þ cells from
both UVB-irradiated and control SDLNs express CTLA-4 (data
not shown). The tryptophan catabolic pathway can be
blocked by the inhibitor 1-methyl tryptophan (Fallarino
et al., 2003). Supplementation of cultures with 200mM
1-methyl tryptophan, tryptophan in excess (10 or 100mg/ml,
Gordon et al., 2005), or with both tryptophan and 1-methyl
tryptophan did not alter the suppressive effects of UVB upon
CD4þ T-cell proliferation in vitro (data not shown). IL-12
reverses the effects of UVB-induced tolerance via initiating
DNA repair mechanisms (Schwarz et al., 1998, 2005).
IL-12 (1 ng/ml) also restored IFN-g concentrations in the
supernatants of hapten-coupled epidermal cells cultured with
splenic T cells from UV-irradiated, hapten-sensitized mice
Table 2. Cellular profile of SDLN of OVA-TCR transgenic mice
Percentage Number of cells/mouse
Cell type Control UVB Control UVB
Total SDLN 1.170.1 107 1.470.2 107*
CD3+CD4+ (of SDLN cells) 5472 4971* 5.870.5 106 6.970.7 106
CD3+CD4+CD25+ (of SDLN cells) 2.370.3 2.870.3* 2.570.3 105 3.870.3 105*
CD25+ (of CD3+CD4+ cells) 4.270.2 5.670.4*
Foxp3+ (of CD3+CD4+ cells) 5.370.6 7.070.3* 2.870.3 105 5.770.9 105*
CD3+CD4+CD25+Foxp3+ (of SDLN cells) 2.970.4 3.670.4* 1.670.2 105 2.670.2 105*
OVA, ovalbumin; SDLN, skin-draining lymph nodes; TCR, T-cell receptor.
Data are shown as mean7SEM for seven experiments where the SDLN cells from three mice are pooled within treatments, 4 days after irradiation with 8 kJ/
m2 UVB.
*A significant difference between control and UVB treatments (Po0.05).
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(Ando et al., 2000). However, the addition of 2 ng/ml rIL-12
every 24 hours to cultures did not reverse the suppressive
effects of UVB upon CD4þ T-cell proliferation (n¼4;
Figure 4d).
DISCUSSION
In this study, CD4þ T cells in the lymph nodes draining
UVB-irradiated skin had the capacity, when transferred into
naive BALB/c mice, to regulate responses to newly intro-
duced antigens (OVA, DNFB). CD4þ T cells from UVB-
irradiated mice also had a reduced capacity to proliferate in
vitro in response to presentation of the OVA323–339 peptide by
co-cultured APC. Depletion of CD25þ cells reversed the
regulatory effects in vitro. There were increases in the
proportion of CD25þ and Foxp3þ cells in the SDLNs of
UVB-irradiated mice. Together, these results imply that
CD4þCD25þ Foxp3þ regulatory T cells are activated and
accumulate in the SDLNs of UVB-irradiated but otherwise
naive mice. The regulatory capacity of CD4þCD25þ
T cells in the SDLNs of UVB-irradiated mice may be antigen
non-discriminatory. Adoptive transfer of CD4þ T cells from
the SDLNs of UVB-irradiated, but non-sensitized OVA-TCR
transgenic mice suppressed CHS responses to an experi-
mental hapten. In addition, adoptively transferred CD4þ
T cells from the SDLNs of UVB-irradiated non-transgenic
BALB/c mice also significantly suppressed CHS responses to
DNFB. It is possible that these cells are specific for skin
antigens that are presented by skin-derived APC following
sensitization with the hapten DNFB. In turn, the CD4þ
CD25þ T regulatory cells would function in an antigen-
nonspecific manner by the secretion of immunoregulatory
cytokines (Schwarz, 2005). CD4þCD25þ T regulatory cells
maintain a partially activated phenotype and may reflect
continuous antigenic peripheral stimulation, perhaps via
tissue antigens presented by resident APCs. This is a situation
that could be exacerbated by irradiation with UVB.
The various mediators and cytokines released from
keratinocytes (Rivas and Ullrich, 1992, Shreedhar et al.,
1998), mast cells (Hart et al., 1997, 1998), and nerves (Khalil
et al., 2001, Townley et al., 2002) that are required for the
systemic immunomodulatory effects of UVB may contribute
towards T regulatory cell accumulation in the SDLNs of
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Figure 4. Reduced in vitro proliferation of CD4þ T cells purified from the SDLNs 4 days after irradiation with 8 kJ/m2 UVB is due to CD4þCD25þ
regulatory T cells. (a) Purified CD4þ T cells from control (unshaded) and UVB-irradiated (shaded) OVA-TCR transgenic mice were depleted of CD25þ cells.
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CD4þ T cells in control treatments was compared with those in UVB treatments, where IL-12 was (UVBþ IL-12) or was not (UVB) also added to control
cultures. For (b) and (d), data are shown as mean7SEM, n¼3.
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irradiated mice. Tumor necrosis factor, a cytokine released by
mast cells, induces hypertrophy of lymph nodes during
infection by recruiting circulating T cells (McLachlan et al.,
2003). Following UVB irradiation, a permissive environment
may be established in the SDLNs with the release of
breakdown products derived from inflamed tissue for the
activation of T regulatory cells, with simultaneous lymph
node hypertrophy (Byrne and Halliday, 2005; Gorman et al.,
2005). CD4þCD25þ cells can be activated via Toll-like
receptors by endogenous molecules released during inflam-
mation (Sakaguchi, 2003). In this study, mice were irradiated
with 4–8 kJ/m2 of UVB, equivalent to 2–3 minimal edemal
doses. Regulatory cell function was dependent upon dose, as
mice receiving 2 kJ/m2 had much reduced suppression of
CD4þ T-cell proliferation in vitro, with reduced hypertrophy
of the SDLNs (data not shown). Thus, inflammation may be
a requirement for T regulatory cell activation/accumulation
in UVB-irradiated mice. Future experimentation should
determine whether both inflammation and TCR engagement
for skin antigens are involved, and their relative contribution
for the activation/accumulation of T regulatory cells in
UVB-irradiated mice.
We observed a significant suppression in the ability of
CD4þ T cells isolated from the SDLNs of mice irradiated
with a single dose of UVB to proliferate in vitro. It is unlikely
that modification of the tryptophan catabolic pathway or
IL-12 secretion by dendritic cells cultured with CD4þ T cells
from UVB-irradiated mice were involved in suppression of
T-cell proliferation in vitro. Depletion of CD4þCD25þ T
cells from cultures or supplementation with IL-2 reversed the
suppressive effects of UVB, implicating CD4þCD25þ
T cells as those responsible for suppression in vitro. The
reduced concentrations of IL-2 in supernatants of cultures
containing CD4þ T cells from UVB-irradiated mice may
indicate how regulatory cells in these cultures suppress in
vitro T-cell proliferation. CD4þCD25þ regulatory T cells
can block IL-2 production by CD4þCD25 effector cells to
limit their proliferation in vitro (Thornton and Shevach,
1998). It is unclear why concentrations of IL-10 and IFN-g
were not also suppressed in vitro. The mechanisms of action
of these cells in vivo are yet to be determined. However, a
possibility is that their suppressive capacity is mediated by
secretion of regulatory cytokines such as IL-10 or TGF-b.
Concomitant with reduced CD4þ T-cell proliferation in
vitro, there was a 24% increase in the proportion of
CD3þCD4þCD25þ Foxp3þ T cells in the SDLNs of
UVB-irradiated OVA-TCR transgenic mice. Foxp3 is the most
accepted marker for CD4þ T regulatory cells (Coffer and
Burgering, 2004), and its expression is largely limited to these
cells (Fontenot et al., 2005). Thus, similar to the reports of
studies of chronically irradiated mice (Loser et al., 2005,
Ghoreishi and Dutz, 2006), following UVB irradiation
T regulatory cells are activated and accumulate in the
SDLNs. This 24% increase in the proportion of
CD4þCD25þ Foxp3þ T cells in the SDLNs of UVB-
irradiated mice parallels the 28% suppression of CHS
responses following the adoptive transfer of 1.5107 cells.
The increased extent of suppression of in vitro proliferation
(39%) by CD4þ T cells from the SDLNs of UVB-irradiated
mice was perhaps due to the expression of OVA-TCR on
CD4þCD25þ T regulatory cells and thus their ability to
suppress OVA-specific responses. Similarly, when adoptively
transferred into BALB/c mice subsequently sensitized to
OVA, at 72 hours post-sensitization there were 34% more
cells harvested from the PLNs from mice receiving CD4þ
T cells from control rather than UVB-irradiated mice.
In earlier studies, a greater number of cells from UVB-
irradiated, hapten-sensitized mice were required to suppress
CHS or delayed-type hypersensitivity responses than the
numbers used in our experiments. Suppression was pre-
viously observed after the transfer of 0.5–1.0108 unfractio-
nated spleen and lymph node cells (Kripke et al., 1983,
Ullrich, 1985; Schwarz et al., 2000, 2004, 2005) or 2107
purified T cells (Moodycliffe et al., 2000). The transfer of
5105 CTLA-4þ cells purified from UVB-irradiated and
hapten-sensitized mice also suppressed CHS responses
(Schwarz et al., 2000). In this study, significantly reduced
CHS responses were observed following the adoptive transfer
of 1.5 107 CD3þCD4þ T cells purified from the SDLNs of
UVB-irradiated, but non-sensitized mice. This was equivalent
to approximately 3 107 unfractionated SDLNs cells per
mouse or 106 CD3þCD4þCD25þ Foxp3þ T cells, where
the proportions of CD3þCD4þ T cells and CD3þCD4þ
CD25þ Foxp3þ cells in the SDLNs of UVB-irradiated OVA-
TCR transgenic were 49 and 3.6%, respectively (Table 2).
Therefore, the numbers of CD4þ T cells transferred are
similar to those previously used to identify the presence of
a T regulatory cell in UV-irradiated mice.
Antigen sensitization was required for the induction of
antigen-specific UV-induced regulatory cells in experiments
performed in the early 1980s (Kripke et al., 1983, Ullrich,
1985). The methods presented in these initial studies differ
from those described in our experiments. Unfractionated
splenic (108) or nylon-wool-enriched T cells from the spleens
of mice irradiated with a high dose of UVB (48–54 kJ/m2) did
not suppress hapten-specific responses in vivo (Kripke et al.,
1983) or in vitro (Ullrich, 1985) unless mice were also
sensitized with the hapten before adoptive transfer or in vitro
stimulation. In our study, a much-reduced dose of UVB
(4–8 kJ/m2) was required to suppress in vitro proliferative
responses of purified CD4þ T cells (495%) from the SDLNs
of UVB-irradiated mice. However, in our preliminary studies,
the proliferation of CD4þ T cells purified from the spleens of
UVB-irradiated OVA-TCR transgenic mice was significantly
suppressed in vitro by 26.578.3% (mean7SEM, n¼ 4). The
induction of regulatory cells in the absence of further
antigenic stimulation may have been dependent upon the
models used in this investigation. However, in our prelimin-
ary studies, adoptive transfer of CD4þ T cells from the
SDLNs of UVB-irradiated, but otherwise naive BALB/c mice
into DNFB-sensitized recipient mice did not suppress ear-
swelling responses. This result complements studies per-
formed by Schwarz et al. (2004) where adoptive transfer
of UVB-induced regulatory T cells from UVB-irradiated
and hapten-sensitized mice did not suppress ear-swelling
responses in already-sensitized mice. The expression of
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CD62L by these T regulatory cells prevented their migration
into the challenge site (Schwarz et al., 2004).
Increased numbers of activated CD4þCD25þ Foxp3þ
regulatory T cells in the SDLNs of UVB-irradiated mice with
the capacity to suppress cellular immune responses has
significant implications for human health. In particular, these
UVB-activated regulatory cells could regulate hapten-specific
responses in recipient mice, which were not previously
exposed to the sensitizing antigen. Mice were irradiated with
a single dose of UVB, and for a Caucasian of average skin
phototype, a dose that is equivalent to sun exposure of
20 minutes of midday summer sunlight in parts of Australia.
This raises important questions as to how the immune status
of humans is altered following exposure to sunlight, and what
impact UV irradiation may have on our ability to combat
infection, allergic disease, and cancer.
MATERIALS AND METHODS
Mice
Mice transgenic for the OVA323–339 (ISQAVHAAHAEINEAGR)-
specific TCR-ab (DO11.10) on a BALB/c background were originally
purchased from the Jackson Laboratory and bred in-house. Female
DO11.10 mice were used between the ages of 8 and 12 weeks.
Expression of OVA323–339-specific TCR-ab on T cells was confirmed
by staining lymph node cells with biotinylated anti-DO11.10 TCR
mAb (KJ1-26, Caltag Laboratories, Burlingame, CA) and then phyco-
erythrin (PE)-Cy5-streptavidin (BD Biosciences, Heidelberg, Ger-
many). Female 8 week-old BALB/c mice were purchased from the
Animal Resources Centre (Murdoch, Western Australia, Australia).
All experiments were performed according to the ethical guidelines
of the National Health and Medical Research Council of Australia
and with approval from the Telethon Institute for Child Health
Research Animal Experimentation Ethics Committee.
UV irradiation
A bank of FS40 sunlamps (Westinghouse, Pittsburgh, PA) emitting a
broad band of UV, 250–360 nm, with 65% of the output in the UVB
range (280–320 nm), was used to irradiate mice in individual
compartments of perspex cages as described previously (Hart
et al., 1997, 1998) The backs of mice (8 cm2) were clean-shaven
24 hours before irradiation. A new sheet of PVC plastic film
(0.22 mm) was taped to the top of each perspex cage immediately
before irradiation to screen wavelengths o290 nm. Sunlamps were
held 20 cm above the cages.
FACS analysis and antibodies
The following anti-mouse mAb were obtained from BD Biosciences:
PE- and PE-Cy5-anti-CD4; APC- and PE-Cy5-labeled streptavidin;
APC-anti-CD25; FITC-anti-CD19; FITC-anti-CD62L; PE-anti-CD11c;
PE-anti-CD69; PE-anti-CTLA-4; PE-anti-IA-IE; biotinylated anti-CD3e;
FITC-anti-CD8a; biotinylated anti-CD44; biotinylated anti-CD54;
biotinylated anti-CD103; and anti-CD16/32. An anti-mouse/rat
Foxp3-FITC staining kit was obtained and used according to the
manufacturer’s instructions (eBioscience, San Diego, CA). For staining
of surface markers, lymph node cells were incubated with antibodies
and staining buffer (phosphate-buffered saline, 0.1% BSA, 0.01%
sodium azide) for 30 minutes, washed, and then fixed in 0.3 ml of 1%
formaldehyde (in phosphate-buffered saline). Data were acquired on a
FACSCalibur flow cytometer (BD Biosciences) and analyzed using
FlowJo software (version 4.6.1, TreeStar Inc., Ashland, OR).
In vitro proliferation
Unfractionated SDLN cells (inguinal, axillary, and brachial) from
UVB-irradiated or control mice were cultured at 105 cells/well in
200ml of Roswell Park Memorial Institute medium with 10% fetal
calf serum and 2mM 2-ME with 1mg/ml of OVA323–339 peptide in
replicates of six. After 48 hours culture at 371C with 5% CO2,
3H-
thymidine (0.25mCi; Amersham TRA-306) was added for a further
48 hours before harvest. CD4þ T cells were isolated from the
SDLNs of UVB-irradiated or control OVA-TCR transgenic mice.
Major histocompatibility complex class IIþ and CD8aþ cells were
removed using supernatant from the TIB-120 hybridoma and rat anti-
CD8a mAb (2.5 mg/ml, BD Biosciences) with M-450 sheep anti-rat
IgG Dynabeads (Dynal Biotech, Oslo, Norway). Rat anti-CD25 mAb
(PC61, 10 mg/ml, BD Biosciences) was used to deplete CD25þ cells
(confirmed by FACS analysis). Purified CD4þ T cells (X95%) were
labeled with 5mM CFSE (Molecular Probes, Eugene, OR). After
washing, cells were resuspended in Roswell Park Memorial Institute
medium with 10% fetal calf serum and 2 mM 2-ME and aliquoted into
round-bottomed 96-well plates at 105 cells/0.1 ml/well. OVA323–339
peptide was added to reach a final concentration of 1 mg/ml. APCs
were prepared from the lymph nodes of naive BALB/c mice by
positive selection using CD11c microbeads in conjunction with the
AutoMACS separation system (Miltenyi Biotec, Germany; 490%
CD11cþ ). APCs were added to CD4þ T cells at varying ratios
(1:10–1:1000) in replicates of six. In some experiments, rIL-2 (BD
Biosciences) or rIL-12 (BD Biosciences) were added to cultures every
24 hours at 2 ng/ml. Alternatively, 200 mM 1-methyl-DL-tryptophan
(1-methyl tryptophan, Aldrich, Castle Hill, New South Wales,
Australia)710 or 100 mg/ml tryptophan (50modified Eagle’s
medium amino acids solution, Gibco, Auckland, New Zealand)
were added to cultures. After incubation for 48–120 hours at 371C in
5% CO2, supernatants were harvested and cells washed and stained
with PE-Cy5-anti-CD4 mAb. With extensive T-cell proliferation,
APCs accounted for o1% of cultured cells. Data were analyzed
using the proliferation algorithm of FlowJo on viable cells, which
were gated according to forward- and side-scatter properties and
CD4 expression where 50,000 events were collected on the flow
cytometer. To calculate percent reduction in proliferation, the
following equation was used: (no. of divided cells in control
culturesno. of divided cells in treatment cultures)Cno. of divided
cells in the control cultures 100. All results shown are of APC
cultured at a 1:100 ratio with CD4þ T cells.
Cytokine detection in supernatants
IL-2, IL-10, and IFN-g were determined using rat anti-mouse IL-2,
IL-10, or IFN-g ELISA capture and detection mAb (BD Biosciences) in
a dissociation-enhanced time-resolved fluorescence immunoassay
with Europium as the label (sensitivity of 25 pg/ml). Mouse rIL-2,
rIL-10, or rIFN-g (BD Biosciences) was used as the standards.
Transfer of CD4þ T cells and subsequent in vivo OVA
sensitization
CD4þ T cells were purified from the SDLNs of UVB-irradiated or
control OVA-TCR transgenic mice, as described above for the
in vitro proliferation assay. Following adoptive transfer of 5 106
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cells, naive BALB/c mice were sensitized by intraperitoneal injection
of 200ml containing 20 mg of OVA protein (Grade V, 98% purity,
Sigma-Aldrich, St Louis, MO) with 4 mg Alum (Alu-Gel-S, 2%
Al(OH)3, Serva, Heidelberg, Germany). After OVA sensitization, the
PLNs (draining the peritoneal cavity) and spleens were removed
from three mice per treatment. Spleen cells were cultured with
and without OVA protein at 100 mg/ml and their incorporation of
3H-thymidine measured as described above for unfractionated
SDLN cells.
CHS responses
Four days after irradiation with 8 kJ/m2 UVB, 1.5 107 CD4þ T
cells purified from the SDLNs of control or UVB-irradiated OVA-TCR
transgenic mice were adoptively transferred into the tail-vein of
naive BALB/c mice (five per group). CD4þ T cells were purified as
described above. Twenty-four hours after adoptive transfer, mice
were sensitized by painting 25 ml 0.5% DNFB (Sigma, St Louis, MO)
diluted in acetone onto the shaved ventral surface. After another
5 days, a CHS response was elicited by painting dorsal and ventral
ear surfaces with 10 ml 0.2% DNFB (in acetone). After 24 hours, the
ear thickness was measured in a blinded manner as described
previously (Hart et al., 1997, 1998). The mean swelling measured in
mice that were challenged but not sensitized with DNFB was
subtracted from ear measurements in each experiment. UVB-
irradiated and sham-irradiated (control) mice were also tested for
their CHS responses 5 days after irradiation.
Real-time reverse transcription-PCR
Total RNA was extracted from cells using the RNeasy Minispin Kit
(Qiagen, Clifton Hill, Victoria, Australia), DNase treated using Turbo
DNA-free (Ambion, Austin, TX), and reverse transcribed using
omniscript reverse transcriptase (Qiagen) according to the manu-
facturer’s protocol with oligo-dT (Promega, Madison, WI) and
Superasin (Geneworks, Hindmarsh, South Australia, Australia).
Reverse-transcribed RNA samples were diluted 1:5 and quantitated
by real-time PCR using QuantiTect SYBR Green Master Mix (Qiagen)
on the ABI PRISM 7900HT (Applied Biosystems, Foster City, CA).
Melting curve analysis was used to assess the specificity of the assay.
Expression levels were determined by a standard curve created from
serial dilutions of the PCR product and normalized to the reference
gene eucaryotic translation elongation factor 1a (Hamalainen et al.,
2001). Primer pairs were as follows: Foxp3, 50-AGGAGAAGCTGG
GAGCTATGC-30 and 50-TGGCTACGATGCAGCAAGAG-30; eucary-
otic translation elongation factor 1a, 50-CTGGAGCCAAGTGCTAA
TATGCC-30 and 50-GCCAGGCTTGAGAACACCAGTC-30.
Statistical analyses
Data were compared using the Student’s t-test, analysis of variance
with the least significant difference post hoc analysis and Pearson’s
correlation coefficient using Microsoft Excel and SPSS 11 statistical
analysis programs as appropriate.
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